Enovis ENOV
NYSE ENOV
$18.71 -0.32 (-1.68%)
As of: Sep 10, 2026 · 10:43 AM EDT

Enovis (ENOV) Income from Discontinued Operations (2016 - 2026)

Enovis' (ENOV) quarterly Income from Discontinued Operations came in at -$39000.0 in Q2 2026, up 68.8% year-over-year from -$23104.3 in Q2 2025, and up 97.64% quarter-over-quarter from -$1.7 million in Q4 2025.

Analysis

Enovis (ENOV) Income from Discontinued Operations (2016 - 2026) Analysis & Trends

Enovis (ENOV) has reported Income from Discontinued Operations for 11 consecutive years, with -$39000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Income from Discontinued Operations rose 68.8% year-over-year to -$39000.0 in Q2 2026; TTM through Jul 2026 was -$1.7 million, a 170.58% decrease from a year earlier, with the FY2025 full-year figure at -$1.9 million, down 173.39% from the prior year.
  • Income from Discontinued Operations was -$39000.0 for Q2 2026 at Enovis, up from -$1.7 million in the prior quarter.
  • Over five years, Income from Discontinued Operations peaked at $54.4 million in Q2 2022 and troughed at -$43.7 million in Q3 2022.
  • A 5-year average of $3.0 million and a median of -$39500.0 in 2025 frame the typical range for Income from Discontinued Operations.
  • Across the five-year window, Income from Discontinued Operations soared 3450.0% in 2024 and sank 487.56% in 2025, its largest moves.
  • Over 5 years, Income from Discontinued Operations stood at $16.3 million in 2022, then slumped by 99.93% to $12000.0 in 2023, then soared by 3450.0% to $426000.0 in 2024, then slumped by 487.56% to -$1.7 million in 2025, then jumped by 97.64% to -$39000.0 in 2026.
  • The last three Income from Discontinued Operations figures came in at -$39000.0 (Q2 2026), -$1.7 million (Q4 2025), and -$40000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Abbott Laboratories 181.94 Bn 176.34 Bn 7.27 Bn -
2 Intuitive Surgical 127.82 Bn 122.60 Bn 1.96 Bn -
3 Medtronic 117.97 Bn 109.15 Bn 6.34 Bn -
4 Stryker 105.64 Bn 102.16 Bn 4.50 Bn -
5 Boston Scientific 65.05 Bn 64.51 Bn 3.85 Bn -
6 Edwards Lifesciences 49.87 Bn 45.62 Bn 1.35 Bn -
7 Alcon 33.26 Bn 31.80 Bn 1.68 Bn -
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -
9 Steris 20.80 Bn 20.32 Bn 684.20 Mn -
10 Enovis 1.08 Bn 1.06 Bn 359.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 3, 2026 -39,000.00
Dec 31, 2025 -1.65 Mn
Oct 3, 2025 -40,000.00
Jul 4, 2025 -93,000.00
Apr 4, 2025 -125,000.00
Dec 31, 2024 426,000.00
Sep 27, 2024 2.24 Mn
Jun 28, 2024 -68,000.00
Dec 31, 2023 12,000.00
Sep 29, 2023 16.61 Mn
Jun 30, 2023 4.80 Mn
Mar 31, 2023 -312,000.00
Dec 31, 2022 16.27 Mn
Sep 30, 2022 -527,000.00
Jul 1, 2022 -43.67 Mn
Apr 1, 2022 54.36 Mn
Dec 31, 2021 14.17 Mn
Oct 1, 2021 40.44 Mn
Jul 2, 2021 71.83 Mn
Apr 2, 2021 52.09 Mn